Ernesto Nakayasu

Scientist

Pacific Northwest National Laboratory
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (26)

Year:

2026

In recent years, high dimensional omics analyses have become more commonplace for investigating complex biological systems. Typically, these studies attempt to identify key biomolecules associated with a particular biological process. Often, machine learning (ML) is used to identify these biomolecules, typically by learning which biomolecules are highly predictive of a treatment, biological outcome, or phenotype. A major challenge of applying ML to high throughput omics is overcoming noise when sample size is limited and unbalanced with respect to tens of thousands of biomolecules measured. Thus, feature selection (the process of reducing the number of predictors) is both a critical and common step in the ML analysis pipeline. While much attention has been given to embedding and wrapping techniques for feature selection in the omics space, filter-based methods for model-free feature selection have appealing theoretical properties. This manuscript evaluates sure screening, a class of filter-based feature selection methods which provide analytical guarantees for true feature set retention. Here, we cover existing feature screening methods based on the sure screening principal, available software, methods to improve feature screening, and contextualize feature screening in the larger discussion of feature selection for omics data analysis. Additionally, a suite of model-free sure screening approaches is applied and compared for several omics biomedical applications in a ML classification context. We identified BcorSIS as the most effective and computationally efficient screening method across various omics datasets, consistently outperforming others like CSIS and DCSIS in runtime.

Year:

2026

This protocol describes a solvent-solvent extraction method to obtain Metabolites, Lipids and Proteins from the same sample. This method, termed MPLEx, can be used on a variety of samples including biofluids (e.g., bronchoalvolar lavage fluid, plasma, blood, urine), mammalian tissues, bacteria, viruses, soil, etc.

Year:

2026

Type 1 diabetes (T1D) is an autoimmune disease where beta cells are destroyed by cytotoxic T cells. Calorie restriction (CR) enhances glucose homeostasis and promotes beta cell longevity and was used as therapeutic strategy for T1D prior to the discovery of insulin. However, a significant knowledge gap remains regarding its effects on beta cells during the pathogenesis of autoimmunity. We demonstrate that CR enhances glucose homeostasis, reduces beta cell load, and delays T1D onset in NOD mice. CR induced a largely post-mitotic beta cell state marked by selective loss of beta cell identity markers, reduced DNA damage and beta cell senescence, and increased PD-L1 within the islet microenvironment. This beta cell phenotype correlates with anti-inflammatory and exhausted immune cell states in the NOD islet. Together, these findings indicate that CR improves glucose homeostasis and remodels the islet microenvironment to promote beta cell longevity via a pro-tolerogenic immune microenvironment that reduces the risk for autoimmune diabetes.

Year:

2026

Plasma extracellular vesicles (EVs) are considered excellent sources for biomarker discovery since they carry signatures of their cellular origin and disease processes. In this paper, we evaluate the potential of plasma EV proteomics analysis for identifying predictive biomarkers of developing type 1 diabetes (T1D), which results from autoimmune destruction of insulin-producing β cells in the islet. We used strong anion exchange beads (Mag-Net) to capture plasma EVs from 19 donors with islet autoimmunity (diagnosed by circulating autoantibodies against islet proteins – AAB+) vs. 17 control individuals and analyzed their protein cargo by mass spectrometry. The analysis identified and quantified 5,480 proteins, a 3.2-fold increase in proteome coverage compared to our previous T1D biomarker proteomics study that used whole plasma depleted of the 14 most abundant proteins. The Mag-Net approach also detected 1,306 out of the 1,717 proteins (76%) that we previously verified as EV proteins. Statistical tests revealed 448 proteins to be differentially abundant in AAB+ vs control volunteers, including 69 previously verified EV proteins. A functional-enrichment analysis resulted in overrepresentation of 25 pathways among the differentially abundant proteins, including pathways related to autoimmune response and lipid metabolism. The capacity of this data to predict AAB+ was tested with a machine learning analysis using a random forest model, resulting in a receiver operating characteristic-area under the curve of 0.81. Overall, our study indicates that plasma EV proteomics analysis can be an exciting approach for studying biomarkers for developing T1D. Significance of the study Type 1 diabetes (T1D) is a disease characterized by the body’s inability to produce insulin and consequently, to control blood glucose levels. Despite the initial trigger being unclear, the disease development process involves an autoimmune response to the islets of Langerhans, resulting in the death of insulin-producing β cells. There is no cure for the disease, and treatment relies on exogenous administration of insulin. Therefore, preventive therapies that block the autoimmune process are attractive for treating T1D. In fact, anti-CD3 antibody (Teplizumab) delays the onset of T1D by 2 years by targeting T cells. Predictive biomarkers for developing T1D are needed to aid the development and implementation of new therapies and to identify the initial trigger and mechanisms of the islet autoimmune process. In this paper, we assess the potential of plasma extracellular vesicle (EV) proteomics analysis for identifying predictive biomarkers of T1D. Our results show excellent potential of the approach, opening opportunities to perform broader studies to identify biomarkers for developing T1D.

Year:

2026

Evolutionary conservation has been considered a hallmark of essential basic functions in cells. Therefore, the study of evolutionarily conserved post-translational modifications (PTMs) can provide insight into their role in protein function. In this context, mass spectrometry can identify and quantify thousands of PTM sites. However, a major bottleneck lies in analyzing the large amounts of data collected by the mass spectrometer. Here we address the need for a protein sequence alignment tool for multiple PTMs across several species. We developed a tool named PTMOverlay that takes peptide identification output files and overlays PTM sites onto multiple protein sequence alignments. Examining 31 bacteria isolates, we combined their protein sequences with select PTM types, including acetylation, phosphorylation, monomethylation, dimethylation, and trimethylation. The tool revealed a variety of conserved modification sites on the bacterial central carbon metabolism. Further structural analysis revealed possible interactions between methylated arginine and lysine residues with phosphothreonine/serine sites on the homodimer interface of enolase. Overall, this tool can parse large amounts of mass spectrometry data and allows for more informed and efficient selection of sites for future studies of protein function.

Year:

2026

Senescence is a nonproliferative survival state that cancer cells can enter to escape therapy. In addition to soluble factors, senescence cells secrete extracellular vesicles (EV), which are important mediators of intercellular communication. To explore the role of senescent cell (SC)–derived EVs (senEV) in inflammatory responses to senescence, we developed an engraftment-based senescence model in wild-type mice and genetically blocked senEV release in vivo, without significantly affecting soluble mediators. SenEVs were both necessary and sufficient to trigger immune-mediated clearance of SCs, thereby suppressing tumor growth. In the absence of senEVs, the recruitment of MHC-II+ antigen-presenting cells (APC) to the senescence microenvironment was markedly impaired. Blocking senEV release redirected the primary target of SC signaling from APCs to neutrophils. Comprehensive transcriptional and proteomic analyses identified six ligands specific to senEVs, highlighting their role in promoting APC–T cell adhesion and synapse formation. APCs activated CCR2+CD4+ TH17 cells, which seemed to inhibit B-cell activation, and CD4+ T cells were essential for preventing tumor recurrence. These findings suggest that senEVs complement the activity of secreted inflammatory mediators by recruiting and activating distinct immune cell subsets, thereby enhancing the efficient clearance of SCs. These conclusions may have implications not only for tumor recurrence but also for understanding senescence during de novo carcinogenesis. Consequently, this work could inform the development of early detection strategies for cancer based on the biology of cellular senescence. Significance: Chemotherapy-treated senescent tumor cells release extracellular vesicles that trigger an immune response and suppress tumor recurrence. See related commentary by Almeida and Melo, p. 833

Year:

2025

Year:

2025

Year:

2025

Type 1 diabetes (T1D) results from the autoimmune destruction of the insulin‐producing β cells of the pancreas. Omega‐3 fatty acids protect β cells and reduce the incidence of T1D, but the mechanism is poorly understood. We have shown that omega‐3 fatty acids reduce pro‐inflammatory cytokine‐mediated β‐cell apoptosis by upregulating the expression of the ADP‐ribosylhydrolase ARH3. Here, we further investigate the β‐cell protection mechanism of ARH3 by performing siRNA analysis of its gene Adprhl2 in MIN6 insulin‐producing cells, subsequent treatment with a cocktail of the pro‐inflammatory cytokines IL‐1β + IFN‐γ + TNF‐α, followed by proteomics analysis. ARH3 regulated proteins from several pathways related to the nucleus (splicing, RNA surveillance, and nucleocytoplasmic transport), mitochondria (metabolic pathways), and endoplasmic reticulum (protein folding). ARH3 also regulated the levels of proteins related to antigen processing and presentation, and the chemokine‐signaling pathway. We further studied the role of ARH3 in regulating the chemokine CXCL9. We found that ARH3 reduces the cytokine‐induced expression of CXCL9, which is dependent on omega‐3 fatty acids. In conclusion, we demonstrate that omega‐3 fatty acids regulate CXCL9 expression via ARH3, which may have a role in protecting β cells from immune attack thereby preventing T1D development. Significance of the Study : Omega‐3 fatty acids have a variety of health benefits. In type 1 diabetes, omega‐3 fatty acids reduce the islet autoimmune response and the disease development. Here, we studied the pathways regulated by the adenosine diphosphate (ADP)‐ribosylhydrolase ARH3, a protein whose expression is regulated by omega‐3 fatty acids. We showed that ARH3 reduces the expression of chemokines in response to omega‐3 fatty acids. This represents an anti‐inflammatory mechanism of omega‐3 fatty acids that might be involved with protection against type 1 diabetes development.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (33)

Jean-Philippe Cartailler

Director, Creative Data Solutions

Vanderbilt University

UNITED STATES
View details

Sarah Tersey

Research Professor

University of Chicago

UNITED STATES
View details

Xiaowei Hu

Research Assistant Professor

University of Virginia

UNITED STATES
View details

Mark A. Atkinson

University of Florida

UNITED STATES
View details

Fengchao Yu

University of Michigan

UNITED STATES
View details

Rohit Kulkarni

Professor and Senior Investigator

Harvard University

UNITED STATES
View details

Matthew Hoare

Associate Professor in Hepatology

University of Cambridge

UNITED KINGDOM
View details

Ferdinando Pucci

Oregon Health & Science University

UNITED STATES
View details

Åke Lernmark

Lund University

SWEDEN
View details

Geremy Clair

Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Ryan Pace

Assistant Professor

University of South Florida

UNITED STATES
View details

Stephen Rich

Harrison Professor and Founding Director (Emeritus)

University of Virginia

UNITED STATES
View details

Joshua Elmore

Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Suvi Maria Virtanen

Karolinska Institutet

SWEDEN
View details

Samuel Payne

Professor of Bioinformatics

Brigham Young University

UNITED STATES
View details

Wei-Jun Qian

Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Javier Flores

Research Assistant Professor

The University of Iowa

UNITED STATES
View details

Robert Egbert

Senior Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Peter Buchwald

University of Miami

UNITED STATES
View details

Denis Mogilenko

Assistant Professor and PI

University of Chicago

UNITED STATES
View details

Michelle McGuire

Director and Professor

University of Idaho

UNITED STATES
View details

Ying Zhu

Genentech Inc

UNITED STATES
View details

Raghavendra Mirmira

Professor

University of Chicago

UNITED STATES
View details

Young-Mo Kim

Senior Scientist

Pacific Northwest National Laboratory

UNITED STATES
View details

Martha Campbell-Thompson

Professor

University of Florida

UNITED STATES
View details

Christopher Anderton

Pacific Northwest National Laboratory

UNITED STATES
View details

Rafael Arrojo e Drigo

Assistant Professor

Vanderbilt University

UNITED STATES
View details

Clayton Mathews

Professor

University of Florida

UNITED STATES
View details

Bobbie-Jo Webb-Robertson

Director

Pacific Northwest National Laboratory

UNITED STATES
View details

Hyeyoon Kim

Assistant Professor

Sookmyung Women's University

SOUTH KOREA
View details

Emily K Sims

Indiana University School of Medicine

UNITED STATES
View details

Alexey Nesvizhskii

Professor

University of Michigan

UNITED STATES
View details

Tom Metz

Staff Scientist / Metabolomics Team Lead

Pacific Northwest National Laboratory

UNITED STATES
View details